Prognostic Value of Impaired Spirometry in Patients with Myocardial Infarction: A Longitudinal Study of Two European Cohorts
Open Access
- 1 April 2026
- journal article
- research article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-11
Abstract
Purpose: The study aimed to investigate the associations between impaired spirometry such as obstructive pattern and preserved ratio impaired spirometry (PRISm) and occurrent cardiovascular events and deaths in patients with acute myocardial infarction. Patients and Methods: Cohort study of 517 patients with age ≥ 40 years and ≥ 10 pack-years of smoking, hospitalized for myocardial infarction at eight sites in Sweden and the United Kingdom. The Vitalograph® COPD-6 device was used to assess the ratio of forced expiratory volume in 1 and 6 seconds (FEV1/FEV6) and FEV1 as a percentage of the predicted value (FEV1%pred). Obstructive pattern was defined as FEV1/FEV6 < 0.7, PRISm as FEV1/FEV6 > 0.7 and FEV1%pred < 80, and normal findings as FEV1/FEV6 ≥ 0.7 and FEV1%pred ≥ 80. Follow-up data were obtained from national registers or follow-up visits. Multivariable Cox regression was used to analyze the associations of obstructive pattern and PRISm with the incidence of acute ischemic cardiovascular events or major adverse cardiovascular events (MACE), respectively, within one year. Results: Obstructive pattern was found in 95 (18%), PRISm in 192 (37%) and normal spirometry in 230 (45%) patients. A cardiovascular event occurred in 21 (4%) and MACE in 28 (5%). Compared with normal spirometry, PRISm was independently associated with both new cardiovascular events (HR (95% CI) 3.44 (1.07– 11.0)) and MACE (4.94 (1.63 to 15.0)), and obstructive pattern with MACE (3.87 (1.08– 13.8)). Further adjustment for cardiac or COPD treatment did not substantially change the results. Conclusion: About half of patients with acute myocardial infarction and a ≥ 10 pack-year smoking history have abnormal spirometry findings. Both obstructive pattern and PRISm are independently associated with increased risk for MACE within one year. We suggest that spirometry should be considered as a routine assessment in patients with smoking history and recent myocardial infarction. Plain Language Summary: Impaired spirometry such as obstructive pattern as in chronic obstructive pulmonary disease (COPD) and preserved ratio impaired spirometry (PRISm) are associated with increased risk of mortality in the general populationThe present study investigated the prevalence and associations of obstructive pattern and PRISm with and occurrent cardiovascular events and deaths in patients with acute myocardial infarction, in cohorts from Sweden and the United KingdomWe found that about half of patients with acute myocardial infarction and a ≥ 10 pack-year smoking history have abnormal spirometry findingsIn patients with acute myocardial infarction and a ≥ 10 pack-year smoking history, obstructive pattern and PRISm are both associated with increased one-year risk of occurrent acute ischemic cardiovascular events and cardiovascular deathsKeywords
This publication has 33 references indexed in Scilit:
- Prevalence of microspirometry-detected chronic obstructive pulmonary disease in two European cohorts of patients hospitalised for acute myocardial infarction: a cross-sectional studyBMJ Open, 2025
- Preserved Ratio Impaired Spirometry and Risks of Macrovascular, Microvascular Complications and Mortality Among Individuals With Type 2 DiabetesChest, 2023
- Preserved Ratio Impaired Spirometry in Relationship to Cardiovascular OutcomesChest, 2022
- Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysisThe Lancet Respiratory Medicine, 2022
- Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US AdultsJAMA, 2021
- Usefulness of the Piko-6 Portable Device for Early COPD Detection in Primary CareArchivos de Bronconeumología, 2018
- The Swedish cause of death registerEuropean Journal of Epidemiology, 2017
- The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)Heart, 2010
- Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan CanadaAnnals of Epidemiology, 2006
- Pulmonary-Function TestingNew England Journal of Medicine, 1994